Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems
Open Access
- 10 December 2022
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 57 (5) , 549-564
Abstract
Summary: Background: There is growing interest in faecal microbiota transplantation (FMT) as a treatment for recurrent Clostridioides difficile infection (CDI), but evidence on the diverse requirements for safe, effective and accessible services is fragmented and limited.Aims: To identify key components of FMT provision relating to the patient care pathway, stool donor pathway and wider healthcare system, and to explore variation in practiceMethods: We conducted a narrative review of the literature and consultations with key clinical experts in the field. Evidence is drawn from high‐income country contexts, with an emphasis on Australia, Canada, Italy and the United Kingdom as case example countries.Results: We identify and discuss key challenges to do with healthcare capacity (workforce, FMT and stool banking facilities), donors and donations, patient access and choice of FMT delivery routes, regulation, costs and reimbursement. We also identify improvement opportunities to increase awareness of FMT and referral processes, physician training, maintaining patient registries and outcome monitoring metrics, in‐country regulatory harmonisation and tackling reimbursement challenges and discuss future research needs.Conclusion: Effectively bringing FMT to patients in a healthcare system requires much more than just the existence of a clinically effective procedure. With FMT being a potentially effective treatment option for recurrent CDI for many patients, a well‐rounded understanding of how appropriate FMT capacity can be built and nurtured is important for both healthcare providers and policymakers seeking to improve patient care.Keywords
Funding Information
- Ferring
This publication has 46 references indexed in Scilit:
- Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infectionAnaerobe, 2018
- Challenges in fecal donor selection and screening for fecal microbiota transplantation: A reviewGut Microbes, 2017
- European consensus conference on faecal microbiota transplantation in clinical practiceGut, 2017
- Understanding the mechanisms of faecal microbiota transplantationNature Reviews Gastroenterology & Hepatology, 2016
- Community-acquired Clostridium difficile infectionsMedecine Et Maladies Infectieuses, 2016
- Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New ZealandInternal Medicine Journal, 2016
- Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota TransplantationDigestive and Liver Disease, 2016
- Rapid evidence assessment: increasing the transparency of an emerging methodologyJournal of Evaluation in Clinical Practice, 2015
- Faecal microbiota transplantation for Clostridium difficile infection in the United KingdomClinical Microbiology and Infection, 2015
- Clostridium difficileInfection: A Comprehensive ReviewCritical Reviews in Microbiology, 2011